News from bio-techne corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 02, 2020, 07:00 ET Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development

Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis...


Nov 11, 2020, 07:00 ET Bio-Techne To Present At The Stephens Annual Investment Conference 2020

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stephens Annual...


Nov 05, 2020, 06:30 ET Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended...


Nov 05, 2020, 06:30 ET Bio-Techne Releases First Quarter Fiscal 2021 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2020. First Quarter FY2021...


Nov 04, 2020, 07:00 ET Bio-Techne To Present At The Stifel 2020 Virtual Healthcare Conference

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stifel 2020...


Nov 02, 2020, 07:00 ET Bio-Techne To Present At The 29th Annual Credit Suisse Virtual Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer, will present at the 29th Annual Credit Suisse Virtual...


Oct 19, 2020, 07:00 ET Bio-Techne Announces Commercial Release Of New SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western

Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module...


Oct 15, 2020, 07:00 ET Bio-Techne Announces ISO 13485:2016 Certification for the Woburn, MA Manufacturing Facility

Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and cytokines today announced that its Woburn, Massachusetts site...


Oct 13, 2020, 07:00 ET Bio-Techne To Host Conference Call On November 5, 2020 To Announce First Quarter 2021 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, November 5, 2020, at 8:00...


Oct 01, 2020, 07:00 ET Bio-Techne Announces Opening Of New Canadian Facility

Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace ...


Sep 30, 2020, 07:00 ET Bio-Techne Announces Grand Opening Of GMP Manufacturing Facility

Bio-Techne Corporation (NASDAQ: TECH) today announced the grand opening of its approximately 61,000 square foot state-of-the-art GMP (Good...


Sep 23, 2020, 07:00 ET Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With Prior Negative Prostate Biopsy

Bio-Techne Corporation (NASDAQ:TECH) today announced an important publication in BMC Urology, entitled A urine-based Exosomal gene expression test...


Sep 22, 2020, 07:00 ET Bio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same Sample

Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release...


Sep 21, 2020, 07:00 ET Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product Portfolio

Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic...


Sep 17, 2020, 07:00 ET Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership

Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome ...


Sep 08, 2020, 07:00 ET Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer

Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of...


Sep 03, 2020, 07:00 ET Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2020 Wells Fargo...


Aug 19, 2020, 08:00 ET Bio-Techne Corporation and Leica Biosystems are Accelerating Disease Research with RNAscope™ COVID-19 Probes and the BOND RX*

Bio-Techne Corporation (NASDAQ:TECH), in partnership with Leica Biosystems, today announced the automation of RNAscope™ COVID-19 probes on BOND RX*,...


Aug 11, 2020, 07:00 ET Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD LlaMABody™ Recombinant Antibody that Blocks Viral Entry

Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds to the...


Aug 06, 2020, 06:00 ET Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler

Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic...


Aug 04, 2020, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2020 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2020. Fourth Quarter FY2020 Snapshot...


Aug 04, 2020, 06:30 ET Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended...


Aug 03, 2020, 07:00 ET Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors

Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board...


Aug 03, 2020, 07:00 ET Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test

Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC...


Jul 21, 2020, 07:00 ET Bio-Techne Announces Launch Of ExoCovid-19 Test For Detection Of SARS-CoV-2 In Patient Samples

Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19...